Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
Condition(s):Malignant Pleural Mesothelioma, AdvancedLast Updated:September 11, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Malignant Pleural Mesothelioma, AdvancedLast Updated:September 11, 2023Recruiting
Condition(s):Malignant TumorLast Updated:October 12, 2023Recruiting
Condition(s):Sarcoma; Carcinoma; Digestive Cancer; Breast Cancer; Lung Cancer; Brain Cancer; Melanoma; Gynecologic Cancer; Head and Neck Cancer; Kidney CancerLast Updated:July 27, 2023Recruiting
Condition(s):Head and Neck Cancer; Esophageal Cancer; Otorhinolaryngologic Neoplasms; Ear Cancer; Nose Cancer; Laryngeal Cancer; Pharyngeal CancerLast Updated:April 26, 2023Recruiting
Condition(s):Sarcoma; Carcinoma; Breast Cancer; Pancreatic Cancer; Colorectal Cancer; Gastric Cancer; Liver Cancer; Lung Cancer; Gynecologic CancerLast Updated:May 16, 2023Recruiting
Condition(s):Lung Cancer; Bronchial Cancer; Non Small Cell Lung Cancer; Small Cell Lung Cancer; Sarcoma; Colorectal Cancer; Gastric Cancer; Liver Cancer; Breast Cancer; Pancreatic Cancer; Head and Neck Cancer; Ovarian CancerLast Updated:June 2, 2023Recruiting
Condition(s):Osteosarcoma; Sarcoma; Soft Tissue Sarcoma; Bone TumorLast Updated:December 14, 2023Recruiting
Condition(s):Ovarian Cancer; Peritoneal Carcinomatosis; Fallopian Tube CancerLast Updated:April 6, 2023Recruiting
Condition(s):Osteosarcoma; Sarcoma; Sarcoma,Soft Tissue; Bone TumorLast Updated:May 9, 2023Recruiting
Condition(s):Cervical Cancer; Endometrial Cancer; Advanced CancerLast Updated:April 14, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.